読み込み中
NASDAQHealthcareMedical - Devices
最新データ
$18.40
+$0.50 · +2.79%
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
前日終値
$18.40
+$0.50 · +2.79%
日中の時刻はETです。市場データは遅延する場合があります。
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
日中レンジ
現在 $18.40
52週レンジ
現在 $18.40
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
96
大幅な割安
センチメント
69
強気
リスク
64
高リスク
モメンタム
20
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
日中レンジ
現在 $18.40
52週レンジ
現在 $18.40
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3.08億 USD | 2.24億 USD | 1.36億 USD | 7501.4万 USD | 3447.3万 USD |
| 売上原価 | 1.12億 USD | 8739.9万 USD | 6514.2万 USD | 3792.9万 USD | 1860.8万 USD |
| 粗利益 | 1.96億 USD | 1.37億 USD | 7104.9万 USD | 3708.5万 USD | 1586.5万 USD |
| 研究開発 | 7127.7万 USD | 6229.8万 USD | 4844.6万 USD | 2898.1万 USD | 1899.3万 USD |
| 販売・一般管理 | 2.29億 USD | 1.71億 USD | 1.32億 USD | 8882.8万 USD | 5103.6万 USD |
| 営業費用 | 3億 USD | 2.34億 USD | 1.8億 USD | 1.18億 USD | 7002.9万 USD |
| 受取利息 | 1221.9万 USD | 1089.5万 USD | 755.1万 USD | 249.7万 USD | 7.6万 USD |
| 支払利息 | 358.6万 USD | 418.4万 USD | 399.5万 USD | 518.3万 USD | 581万 USD |
| 減価償却費と償却費 | 639万 USD | 523.4万 USD | 380.7万 USD | 284.1万 USD | 332.4万 USD |
| 営業利益 | −1.04億 USD | −9661.4万 USD | −1.09億 USD | −8072.4万 USD | −5416.4万 USD |
| 純利益 | −9557.2万 USD | −9141.3万 USD | −1.06億 USD | −8715.4万 USD | −5985.3万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI3621.31万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM2635.54万0.03%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB2634.97万0.01%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK1510.44万0.03%447億 USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF1400.84万0.01%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO936.56万0.07%139.17億 USD0.24%$356.78+0.94%
Global X - Robotics & Artificial Intelligence ETFBOTZ883.89万0.26%33.44億 USD0.68%$35.48+1.87%
Vanguard Russell 2000 ETFVTWO684.41万0.04%180億 USD0.06%$112.66+0.50%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOGlobal X - Robotics & Artificial Intelligence ETFBOTZVanguard Russell 2000 ETFVTWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
